299 related articles for article (PubMed ID: 26302862)
41. Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation.
Kumari N; Pathak K
Curr Drug Deliv; 2012 Jan; 9(1):74-84. PubMed ID: 22023207
[TBL] [Abstract][Full Text] [Related]
42. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
Patel UL; Chotai NP; Nagda CD
Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
[TBL] [Abstract][Full Text] [Related]
43. Drug release from injectable depots: two different in vitro mechanisms.
Wang L; Venkatraman S; Kleiner L
J Control Release; 2004 Sep; 99(2):207-16. PubMed ID: 15380631
[TBL] [Abstract][Full Text] [Related]
44. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
[TBL] [Abstract][Full Text] [Related]
45. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
Li XY; Zhu ZJ; Cheng AY
Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
[TBL] [Abstract][Full Text] [Related]
46. Moxifloxacin HCl-Incorporated Aqueous-Induced Nitrocellulose-Based In Situ Gel for Periodontal Pocket Delivery.
Senarat S; Rojviriya C; Sarunyakasitrin K; Charoentreeraboon J; Pichayakorn W; Phaechamud T
Gels; 2023 Jul; 9(7):. PubMed ID: 37504451
[TBL] [Abstract][Full Text] [Related]
47. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
[TBL] [Abstract][Full Text] [Related]
48. In Situ Forming Depot as Sustained-Release Drug Delivery Systems.
Kanwar N; Sinha VR
Crit Rev Ther Drug Carrier Syst; 2019; 36(2):93-136. PubMed ID: 30806210
[TBL] [Abstract][Full Text] [Related]
49. Lincomycin HCl-Loaded Borneol-Based In Situ Gel for Periodontitis Treatment.
Puyathorn N; Lertsuphotvanit N; Chantadee T; Pichayakorn W; Phaechamud T
Gels; 2023 Jun; 9(6):. PubMed ID: 37367165
[TBL] [Abstract][Full Text] [Related]
50. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide.
Sheshala R; Hong GC; Yee WP; Meka VS; Thakur RRS
Drug Deliv Transl Res; 2019 Apr; 9(2):534-542. PubMed ID: 29484530
[TBL] [Abstract][Full Text] [Related]
51. Preparation of floating alginate gel beads for drug delivery to the gastric mucosa.
Murata Y; Kofuji K; Kawashima S
J Biomater Sci Polym Ed; 2003; 14(6):581-8. PubMed ID: 12901439
[TBL] [Abstract][Full Text] [Related]
52. Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials.
Singh VK; Pramanik K; Ray SS; Pal K
AAPS PharmSciTech; 2015 Apr; 16(2):293-305. PubMed ID: 25277240
[TBL] [Abstract][Full Text] [Related]
53. Influence of substitution on the rheological properties and gelation of hydroxyethyl cellulose solution in NaOH-water solvent.
Wang W; Li F; Yu J; Navard P; Budtova T
Carbohydr Polym; 2015 Jun; 124():85-9. PubMed ID: 25839797
[TBL] [Abstract][Full Text] [Related]
54. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
[TBL] [Abstract][Full Text] [Related]
55. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
[TBL] [Abstract][Full Text] [Related]
56. Formulation development of smart gel periodontal drug delivery system for local delivery of chemotherapeutic agents with application of experimental design.
Dabhi MR; Nagori SA; Gohel MC; Parikh RK; Sheth NR
Drug Deliv; 2010; 17(7):520-31. PubMed ID: 20553104
[TBL] [Abstract][Full Text] [Related]
57. Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process.
Kempe S; Metz H; Mäder K
J Control Release; 2008 Sep; 130(3):220-5. PubMed ID: 18611421
[TBL] [Abstract][Full Text] [Related]
58. Retention of antimicrobial activity after reconstitution of doxycycline gel.
Dennis M; Wilson T; Woodward T
J Vet Dent; 2012; 29(2):84-7. PubMed ID: 23008856
[TBL] [Abstract][Full Text] [Related]
59. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels.
Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS
Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681
[TBL] [Abstract][Full Text] [Related]
60. Rheo-dissolution: A new platform for the simultaneous measurement of rheology and drug release.
Senjoti FG; Ghori MU; Diryak R; Conway BR; Morris GA; Smith AM
Carbohydr Polym; 2020 Feb; 229():115541. PubMed ID: 31826516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
